Welcome to the all-new Vetlearn

  • Vetlearn is getting a new home. Starting this fall,
    Vetlearn becomes part of the NAVC VetFolio family.

    You'll have access to the entire Compendium and
    Veterinary Technician archives and get to explore
    even more ways to learn and earn CE by becoming
    a VetFolio subscriber. Subscriber benefits:
  • Over 500 hours of interactive CE Videos
  • An engaging new Community for tough cases
    and networking
  • Three years of NAVC Conference Proceedings
  • All-new articles (CE and other topics) for the entire
    healthcare team

To access Vetlearn, you must first sign in or register.


  • Registration for new subscribers will open in September 2014!
  • Watch for additional exciting news coming soon!
Become a Member

Reference Desk September 2011

Pfizer recalls Dexdomitor and Antisedan

    Pfizer Animal Health is voluntarily recalling one lot each from its Antisedan and Dexdomitor sterile injectable solutions.

    Dexdomitor is used as a sedative and analgesic in dogs and cats, as well as a preanesthetic to general anesthesia. Antisedan is used to reverse the sedative and analgesic effects of Dexdomitor.

    Pfizer announced Sept. 16, 2011 that the two lots may contain foreign particles originating from a glass vial manufacturing defect. The affected lots are lots 1399276 of Antisedan (expiration: March 2014) and 1391999 of Dexdomitor (expiration: January 2014).

    According to a Pfizer news release, Pfizer and manufacturing partner Orion Corporation implemented the recall after a scientific assessment that the affected lots could result in serious negative health effects.

    Customers can contact Pfizer’s Veterinary Medical Information and Product Support group with questions or for more information at 800-366-5288.

    Source: Pfizer Animal Health


    Did you know... In dogs, up to 40% of enrofloxacin is converted to ciprofloxacin.

    Stay on top of all our latest content — sign up for the Vetlearn newsletters.
    • More